Weight Loss and Slowing Growth Rate in Pediatric Patients with ADHD In a controlled trial of VYVANSE in pediatric patients ages 6 to 12 years (Study 1), mean weight loss from baseline after 4 weeks of therapy was -0.9, -1.9, and -2.5 pounds, respectively, for patients receiving 30 mg, 50 mg, and 70 mg of VYVANSE, compared to a 1 pound weight gain for patients receiving placebo
This multi-system approach explains why GLP-1 before and after results look so different from traditional diet results
Determining liability is a major part of PFAS litigation, as it involves identifying the manufacturers and users of PFAS chemicals responsible for environmental contamination
471,472 It was approved by the FDA in March 2022 for moderate to severely active UC at a dose of 45 mg per day for 8 weeks and then 15 or 30 mg per day for maintenance treatment
Proactively drinking fluids helps you stay ahead of dehydration
Im sure youve heard a lot about GLP-1s from social media influencers, advertisements, and well-meaning family and friends